Navigation Links
Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card

SAN DIEGO, Nov. 23 /PRNewswire/ -- Victory Pharma, Inc. ("Victory") announced today the launch of NAPRELAN® Dose Card, a further extension of Victory's NAPRELAN franchise.

NAPRELAN Dose Card is designed for patients who require relief from mild to moderate pain and inflammation associated with primary dysmenorrhea and acute tendinitis and bursitis. It is also designed for patients suffering from rheumatoid arthritis or osteoarthritis who may be receiving other therapies and need additional anti-inflammatory/analgesic activity for a limited time. The Dose Card provides a ten day, tapered dose regimen in a single blister pack, with three days of NAPRELAN therapy at the maximum daily dose of 1,500 mg (i.e., two 750 mg tablets), followed by a taper to 1,000 mg per day (two 500 mg tablets) for an additional seven days of therapy.

Commenting on NAPRELAN Dose Card, Victory's Chief Executive Officer Matthew Heck stated, "This product concept is the result of substantial input from our clinical advisors and other members of the pain management community. It was designed to enable healthcare providers to treat pain and inflammation aggressively for a limited period of time and then taper NAPRELAN back to a standard dosage strength. This customized dosage regimen in a single prescription and product configuration will aid in patient compliance. We are excited about the prospects for NAPRELAN Dose Card based upon market feedback."

Victory will promote NAPRELAN Dose Card through its 160 person U.S. field sales organization.

About Victory Pharma

Founded in 2003, Victory Pharma, Inc. is a privately held specialty pharmaceutical company headquartered in San Diego, CA focused on acquiring, developing, and marketing products to treat pain and related conditions. Victory markets its lead product, NAPRELAN® (naproxen sodium) Controlled-Release Tablets and other pain products to pain management specialists, rheumatologists, orthopedic surgeons, and selected primary care physicians through its physician office-based field sales force. Victory is also developing proprietary products for the treatment of chronic pain and common opioid-induced side effects. Further information regarding Victory Pharma is available at

NAPRELAN ® is a trademark of Elan Corporation, plc.

SOURCE Victory Pharma, Inc.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers notch a victory toward new kind of cancer drug
2. Stupak Amendment Passes in Final House Health Care Bill. A First Step to Victory, but Many Battles Ahead. We Must Rejoice With Caution.
3. Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers; $1 Increase Gives State Second Highest Cigarette Tax in the Nation
4. Mother & Daughter Celebrate Victory Over Meth
5. District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
6. Victory Pharma, Inc. Announces FDA Accepts MGX006 NDA for Review
7. President Obama Delivers Historic Victory for Americas Kids and Health over Tobacco
8. American College of Chest Physicians Celebrates the Nations Victory for Tobacco Control
9. Mississippi Tobacco Tax Increase is a Victory for Kids and Taxpayers
10. Victory! Colombian Government Cuts Price of Abbotts Lifesaving AIDS Drug Kaletra 55%, Says AHF
11. Hawaii Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
Breaking Medicine Technology: